A. Hertel

Positron Emission Tomography–Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial

Ulrich Dührsen, Stefan Müller, Bernd Hertenstein et al. · Journal of Clinical Oncology · 2018 · 238 citations

Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial

Ursula Nestle, Tanja Schimek‐Jasch, Stephanie Kremp et al. · The Lancet Oncology · 2020 · 169 citations

Engineering, Oncologic Imaging, Medical Imaging +9

99Tcm-labelled anti-CEA monoclonal antibody for tumour immunoscintigraphy

R. P. Baum, A. Hertel, Matthias Lorenz et al. · Nuclear Medicine Communications · 1989 · 100 citations

Positron Emission Tomography (PET) for Staging and Evaluation of Response to Treatment in Patients with Hodgkin's Disease

Eckhart Weidmann, Bianca B. Aican, A. Hertel et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1999 · 83 citations

Intraoperative gamma probe detection of neuroendocrine tumors.

Stefan Adams, Richard P. Baum, A. Hertel et al. · PubMed · 1998 · 83 citations